Arcus Biosciences, Inc. (RCUS) stock analysis
RCUS · Arcus Biosciences, Inc.
Latest recorded price: USD 16.86
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 30.2%, free cash flow margin -196.0%, ROIC -296.1%. The model flags 2 risk signals for this company (2 high severity).
Similar companies in Healthcare
- Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
- Relay Therapeutics, Inc. (RLAY)
- Roivant Sciences Ltd. (ROIV)
- Royalty Pharma plc (RPRX)
- Revolution Medicines, Inc. (RVMD)
- Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX)
- Rhythm Pharmaceuticals, Inc. - Common Stock (RYTM)
- SELLAS Life Sciences Group, Inc. - Common Stock (SLS)